Cargando…

Blood Hyperviscosity: A Novel Link Between Hyperinflammation and Hypercoagulability in COVID-19

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Bonaventura, Aldo, Potere, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the American College of Cardiology Foundation. Published by Elsevier. 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535031/ https://www.ncbi.nlm.nih.gov/pubmed/35863849 http://dx.doi.org/10.1016/j.jacc.2022.04.061

Ejemplares similares

COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?
por: Maier, Cheryl L, et al.
Publicado: (2020)

Blood hyperviscosity in acute and recent COVID-19 infection
por: Shaik, Aleesha, et al.
Publicado: (2022)

Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation
por: Bonaventura, Aldo, et al.
Publicado: (2022)

Hyperviscosity syndrome revisited
por: Gangopadhyay, Debasree, et al.
Publicado: (2022)

Low-dose subcutaneous tocilizumab to prevent disease progression in patients with moderate COVID-19 pneumonia and hyperinflammation
por: Potere, Nicola, et al.
Publicado: (2020)

Hyperviscosity syndrome in COVID-19 and related vaccines: exploring of uncertainties
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

Expected Viscosity After COVID-19 Vaccination, Hyperviscosity and Previous COVID-19
por: Joob, Beuy, et al.
Publicado: (2021)

The Relationship between Seminal Fluid Hyperviscosity and Oxidative Stress: A Systematic Review
por: Barbagallo, Federica, et al.
Publicado: (2021)

Immunopathology of Hyperinflammation in COVID-19
por: Gustine, Joshua N., et al.
Publicado: (2021)

Platelet activity and hypercoagulation in type 2 diabetes
por: Pretorius, Lesha, et al.
Publicado: (2018)

Management of hyperinflammation in COVID-19 patients
por: Suberviola, Borja, et al.
Publicado: (2022)

Post-COVID-19 arthritis: is it hyperinflammation or autoimmunity?
por: Taha, Sara Ibrahim, et al.
Publicado: (2022)

COVID-19 Hyperinflammation: What about Neutrophils?
por: Didangelos, Athanasios
Publicado: (2020)

Frontal encephalopathy related to hyperinflammation in COVID-19
por: Cani, Ilaria, et al.
Publicado: (2020)

Delving beneath the surface of hyperinflammation in COVID-19
por: Reddy, Kiran, et al.
Publicado: (2020)

Hyperinflammation with COVID-19: The key to patient deterioration?()()
por: Haigh, Kathryn, et al.
Publicado: (2020)

Lymphoid morphology, hyperviscosity and extensive immunoglobulin deposits in myeloma
por: Sehgal, Tushar, et al.
Publicado: (2022)

COVID-19 and Neutrophils: The Relationship between Hyperinflammation and Neutrophil Extracellular Traps
por: Borges, Leandro, et al.
Publicado: (2020)

Cerebral Infarction in IgG Multiple Myeloma with Hyperviscosity
por: Park, Man-Seok, et al.
Publicado: (2005)

Hyperviscosity retinopathy as the initial presentation of aggressive multiple myeloma
por: Kuo, Hua-Hsuan, et al.
Publicado: (2020)

The Burden of Hypercoagulability in COVID-19
por: Kim, Madeleine, et al.
Publicado: (2022)

Thromboinflammation and the hypercoagulability of COVID‐19
por: Connors, Jean M., et al.
Publicado: (2020)

Biomarkers of Hypercoagulability in COVID-19
por: Wada, Hideo
Publicado: (2023)

Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation
por: Randeria, Shehan N., et al.
Publicado: (2019)

A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling
por: Hasan, Djo, et al.
Publicado: (2021)

Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19
por: Tanner, Tamara, et al.
Publicado: (2020)

IgGs drive COVID-19 myeloid hyperinflammation
por: Park, Matthew D.
Publicado: (2020)

Attenuating hyperinflammation in COVID-19: A change in paradigm?
por: Molnar, Zsolt, et al.
Publicado: (2020)

ACEi reduces hypertension-induced hyperinflammation in COVID-19
por: Lim, Gregory B.
Publicado: (2021)

Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment
por: Bratseth, Vibeke, et al.
Publicado: (2012)

Total Antioxidant Capacity and Lipid Peroxidation in Semen of Patient with Hyperviscosity
por: Layali, Issa, et al.
Publicado: (2015)

Hyperviscosity Syndrome in Paraprotein Secreting Conditions Including Waldenstrom Macroglobulinemia
por: Weaver, Allison, et al.
Publicado: (2020)

Hyperviscosity Retinopathy and Immunogammopathy Maculopahy as New Onset of Multiple Myeloma
por: Ferreira Santos da Cruz, Natasha, et al.
Publicado: (2021)

High-dose intravenous vitamin C attenuates hyperinflammation in severe coronavirus disease 2019
por: Xia, Guozhi, et al.
Publicado: (2021)

COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern on cases with underlying liver problem
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Change of Safety Interval from Hyperviscosity Problem in COVID-19 Vaccine Recipient with Underlying Diabetic Problem
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Hyperinflammation Reduces Midazolam Metabolism in Critically Ill Adults with COVID-19
por: Smeets, Tim J. L., et al.
Publicado: (2022)

COVID-19 and Hypercoagulability: A Review
por: Kichloo, Asim, et al.
Publicado: (2020)

COVID-19 versus HIT hypercoagulability
por: Warkentin, Theodore E., et al.
Publicado: (2020)

Current Overview on Hypercoagulability in COVID-19
por: Singhania, Namrata, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hulv0sevjot4e26fg2fvl0httb